Status:
COMPLETED
Assessment of Glucose Concentrations in People Without Diabetes Mellitus After Standardized Meals and in Daily Life
Lead Sponsor:
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Conditions:
Subjects Without Diabetes Mellitus
Assessment of Glucose Concentrations
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Participants will perform blood glucose monitoring (BGM) over the course of 14 days and, in parallel, wear continuous glucose monitoring (CGM) systems. Because current CGM systems typically achieve a ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Written informed consent
- Subject is legally competent and has the capacity to understand character, meaning and consequences of the study
- Subject is willing to refrain from intake of salicylic acid and ascorbic acid and medication and/or compounds containing these substances
Exclusion
- Anamnestically known diabetes mellitus
- Severe acute or chronic disease with potential risk of being adversely affected by the study procedures (at the study physician's discretion)
- Current constitution that compromises the subject's capability to participate in the study (at the study physician's discretion)
- Pregnancy or lactation period
- Known severe skin reactions to adhesives
- Blood donation within the previous two months (according to the subject's statement)
- Language or other barriers potentially compromising an adequate compliance with study procedures
Key Trial Info
Start Date :
January 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2019
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03405415
Start Date
January 27 2018
End Date
July 10 2019
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Ulm, Baden-Wurttemberg, Germany, 89081